IRIS Regtech Solutions is one of those companies that sounds boring until you realise it sits exactly where modern capitalism sweats the most: compliance. Regulators want filings, enterprises want to avoid regulatory embarrassment, banks want structured data, exchanges want clean disclosures, and nobody wants to manually stitch XBRL, ESG, tax, filings, analytics, and reporting with Excel plus prayer. So IRIS sells software into that pain. On paper, this is a nice little SaaS-and-SupTech story with global clients, regulator-facing products, growing ARR, a much stronger balance sheet after the TaxTech divestment, and a footprint that reaches from India to Qatar to South Africa to Kuwait and beyond. In reality, this is also the sort of company where one exceptional gain can walk into the P&L, steal the microphone, and make every popular valuation ratio look like it has consumed bhang on Holi. Revenue is growing, yes. Cash has jumped, yes. Net worth has ballooned, yes. But promoter holding has drifted down to 34.63%, the rating agency has kept the company in an “issuer not cooperating” bucket for its bank facilities, and the trailing earnings include a giant divestment-related gain that makes raw P/E look smarter than it actually is. So what do we have here: a genuine RegTech franchise getting reloaded with capital, or a financial statement where the main character is one-off income wearing sunglasses indoors? That is the central masala of this case.
2. Introduction
IRIS is not in the glamorous end of technology. It is not selling memes, cloud kitchens, crypto dreams, or AI wrappers pretending to be a “platform.” It sits in the plumbing. And as every Indian household knows, plumbing becomes very important exactly when it breaks.
The company’s stated focus is RegTech and SupTech. That means software for enterprises to prepare and file disclosures, and software for regulators to collect, validate, analyse, and use those disclosures. It operates through three broad buckets: Collect, Create, and Consume. In plain English, IRIS helps people submit compliance data, helps others create those submissions, and then helps someone else analyse the mess afterward. That is not sexy. It is, however, sticky.
Now the juicy part. In FY26, the company divested its TaxTech business to Sovos. That deal changed the balance sheet dramatically. Management said cash and investments were around ₹170 crore after the transaction, net worth jumped to about ₹189 crore from ₹76 crore in March 2025, and book value rose to about ₹92 from ₹37. Suddenly the company moved from “steady niche software business” to “smallcap with ammo.” Management’s own language was basically: now we have gunpowder, and we intend to use it for SaaS growth. That is a serious statement, especially when the company says its focus is “unequivocally” on ARR growth.
But before anyone starts doing bhangra over the cash pile, the other side of the ledger needs a seat at the wedding too. India Ratings maintained the company’s bank loan facilities at IND B-/Negative in the non-cooperating category in August 2025, explicitly noting that the issuer did not adequately participate in the surveillance exercise and warning users to exercise caution. That does not automatically make the business bad, but from a governance optics angle, it is the equivalent of showing up to a viva and telling the examiner, “Sir, marks toh de hi doge.”
So IRIS today is a strange and interesting beast. It has a global niche. It has regulator-grade clients. It has a cash-rich post-divestment balance sheet. It has decent operating history. It also has noisy earnings, lumpy revenue in parts of the business, falling promoter shareholding over time, and governance signals that deserve more than a polite cough. Reader, would you call this a hidden gem, or a spreadsheet that needs adult supervision? Hold that thought.
3. Business Model – WTF Do They Even Do?
Let us decode this without using corporate PowerPoint perfume.
IRIS essentially sells regulatory data infrastructure.
Its Collect division builds software that regulators and public institutions can use to collect structured filings from entities. Think of it like a disciplined front desk clerk who rejects incomplete forms before they reach the boss.
Its Create division gives enterprises software to prepare, structure, validate, and file reports with regulators. This includes XBRL, iXBRL, disclosure management, ESG reporting, GST-related tools, and similar workflows. This is the bit where CFO offices pay to avoid ugly mistakes.
Its Consume division is the analytics side. Once data is filed, someone wants to search it, compare it, analyse it, or build APIs around it. IRIS monetises that layer too.
The interesting thing is that this is not a one-product circus. The company mentions products like iFILE, iDEAL, Carbon, IRIS GST, E-invoicing and iConnect. It also serves a fairly international client base across Asia Pacific, Europe and the UK, the Middle East, Africa, America, and India. In FY23, India was 38% of revenue, but the rest was meaningfully global. That matters because compliance software with regulator relationships tends to age well if execution is solid. Once a regulator installs your plumbing, it does not wake up every Tuesday wanting a new vendor because someone’s nephew made a better app.
The post-divestment strategy is even more specific. According to the November 2025 concall summary, management wants to push ARR-led scaling in RegTech, especially IRIS CARBON and disclosure management. CARBON ARR reportedly increased from ₹28.4 crore to ₹32.4 crore in H1 FY26, with much of the growth coming from disclosure management. They also said ticket sizes here are materially higher than traditional XBRL work, which means one customer win can punch above its weight. That is the nice part. The less nice part is that management is deliberately spending more on sales, marketing and product to chase this ARR, which means near-term margins are being treated like sacrificial goats at a village festival.
There is also SupTech, which looks like the steadier cousin. Management said SupTech margins run around 30% operating margin, and flagged wins such as Qatar Central Bank and Qatar Tax Authority. Then there is DataTech, which is still pre-revenue, and Peridot, an MSME platform whose monetisation model is still in pilot mode. So not every project here is ready to pay the rent.
In short: the business model is real, specialised, globally relevant, and sticky. It is also not simple. This is not a chai stall with one menu item. It is a compliance buffet, and some dishes are already profitable while others are still being cooked behind the kitchen curtain.
4. Financials Overview
Result-type lock: the latest official heading in the dump is Quarterly Results, so EPS treatment here stays quarterly-based. For Q3, the strict annualisation rule is: average of Q1, Q2 and Q3 EPS multiplied by 4. That gives annualised EPS of about ₹79.35 using Q1 FY26 EPS of ₹0.09, Q2 FY26 EPS of ₹56.84, and Q3 FY26 EPS of ₹2.58. The problem, of course, is that Q2 included a giant exceptional gain from the TaxTech divestment, so the statutory annualised P/E becomes mathematically valid and economically hilarious.
Quarterly comparison
Metric
Latest Quarter (Dec 2025)
Same Quarter Last Year (Dec 2024)
Previous Quarter (Sep 2025)
YoY %
QoQ %
Revenue
₹35.59 Cr
₹32.83 Cr
₹28.56 Cr
8.41%
24.61%
EBITDA / Operating Profit
₹5.07 Cr
₹5.20 Cr
₹0.14 Cr
-2.50%
3521.43%
PAT
₹5.31 Cr
₹3.59 Cr
₹116.85 Cr
47.91%
-95.46%
EPS
₹2.58
₹1.77
₹56.84
45.76%
-95.46%
The table tells two stories.
Story one: the core operating business recovered nicely in Q3 from the Q2 margin collapse. Revenue improved sharply QoQ, EBITDA bounced, and PAT normalised from the one-time divestment madness.
Story two: comparing Q3 with Q2 for PAT and EPS is like comparing a normal family wedding with the Ambani baraat. Q2 had exceptional income. So yes, Q3 looks down 95% QoQ on profit. That says more about Q2’s extraordinary gain than Q3’s actual health.
This 3.07x P/E is technically correct under the locked quarterly annualisation rule, but it is not a sensible representation of steady-state earnings, because the average includes the exceptional divestment gain in Q2. The market itself clearly knows this, which is why the screen shows a much higher stock P/E of 48.78x based on trailing numbers. So investors should read IRIS through two lenses:
Statutory lens: earnings got turbocharged by the sale.
Business lens: recurring profitability is much lower, and margins are being consciously reinvested into ARR growth.
If you only read the P/E screen here, congratulations, you have successfully been fooled by accounting theatre.
5. Valuation Discussion – Fair Value Range Only
This section is interpretative, and the numbers below should be treated as illustrative valuation ranges based on the dump, not as certainty delivered from Mount Sinai.
A) P/E method
Because TTM earnings and Q2 FY26 EPS are distorted by the divestment gain, a cleaner earnings anchor from the dump is FY25 EPS of ₹6.34. Peer P/Es in the table range from around 11.4x for Tanla, 13.7x for Nucleus, 25.4x for Oracle Financial Services, and 36.8x for C.E. Info System, with absurd outliers ignored because no one needs valuation advice from a statistical circus.
Using a practical range of 18x to 28x on FY25 EPS:
Lower value = ₹6.34 × 18 = ₹114
Upper value = ₹6.34 × 28 = ₹178
B) EV/EBITDA method
The dump shows:
Enterprise value = ₹451 Cr
FY25 operating profit = ₹19 Cr
FY25 depreciation = ₹2 Cr
Approximate FY25 EBITDA = ₹21 Cr
If we apply an 18x to 24x EV/EBITDA band for a niche software/regulatory tech player with cash strength but uneven earnings quality:
Lower EV = ₹21 × 18 = ₹378 Cr
Upper EV = ₹21 × 24 = ₹504 Cr
Management said post divestment cash/investments were around ₹170 Cr and debt is minimal. If we loosely translate that to equity value support, the EV-based reading suggests the market is paying a premium for the cash-backed pivot and ARR optionality, but not handing out free laddoos. On a practical basis, this method broadly indicates an equity zone around ₹170 to ₹220 per share, depending on how much one credits the cash and how much one discounts execution risk.
C) DCF method
For a simple illustrative DCF, I am using:
Base free cash flow = ₹21 Cr (FY25)
Growth range = 8% to 12%
Discount rate = 12% to 14%
Terminal growth = 3% to 4%
This yields an indicative equity value band of roughly ₹240 Cr to ₹380 Cr, which translates to approximately ₹117 to ₹184 per share using roughly 2.06 crore shares.
Valuation summary
Method
Fair Value Range
P/E
₹114 – ₹178
EV/EBITDA
₹170 – ₹220
DCF
₹117 – ₹184
Blended educational range
A reasonable blended educational range comes to roughly:
₹125 to ₹195 per share
The current market price around ₹243 suggests the market is already pricing in not just the current business, but also successful deployment of the post-divestment cash pile into higher ARR growth. In other words, the market is not valuing IRIS like a sleepy filing vendor. It is valuing it like a reinvestment story with optionality.
This fair value range is for educational purposes only and is not investment advice.
6. What’s Cooking – News, Triggers, Drama
Now we enter the masala drawer.
In July 2025, management said IRIS would divest its TaxTech business to Sovos for about ₹151 crore, with proceeds intended to fund RegTech and SupTech growth. By August 2025, the GST ASP services transfer and the 95% stake sale in IRIS Logix had been completed. By Q2 FY26, the P&L was carrying a gigantic exceptional gain from this sale. This is not a minor corporate event. This is the event. It changed the capital structure, the strategic posture, and the entire tone of the company.
Then come the order wins. In October 2025, IRIS won a six-year XBRL SupTech contract from the Qatar General Tax Authority. In January 2026, it won a seven-year design, development and maintenance contract for IFSCA through NEC. In March 2026, the company announced a multi-year Brazil Oil & Gas mandate for IRIS Carbon ESG and disclosure reporting, with execution by FY27. Contract values in some of these wins were confidential, which is standard enough, though every investor secretly wants the number the way aunties want to know the wedding budget.
Management changes also show up. Vinod Agarwala ceased as Chairman and independent director in November 2025 after completing his term. Bhaswar Mukherjee was appointed Chairman in February 2026. A CRO appointment and the incorporation of a wholly owned subsidiary, IRIS Data Solutions Private Limited, were also disclosed. New subsidiary, new contracts, new cash, new chairman. Quite a busy season for a company supposedly selling boring compliance software.
The concall adds even more flavour. Management said CARBON ARR rose 14% in H1 FY26, largely through Disclosure Management. They also admitted IDEAL revenue was hit by delays in purchase decisions from banks, and that the business has some lumpiness because licence and implementation revenue recognition is uneven. Translation: part of the business behaves like a recurring SaaS story, and part still occasionally behaves like Indian monsoon planning.
So what is the trigger list?
Can management convert the huge post-sale cash pile into durable ARR growth?
Can CARBON and disclosure management scale without permanently wrecking margins?
Can SupTech keep acting like the sober sibling in the family?
Can governance optics improve, especially after the rating-agency non-cooperation label?
And tell me honestly: when a company says “we now have ammunition,” do you hear disciplined capital allocation, or do you hear a smallcap founder reaching for a flamethrower?
